Arginine Methylation in Alternative Splicing: Implications for Cancer Therapy

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Background:

• Arginine methylation is a key post-translational modification regulating RNA splicing and cellular homeostasis.
• Its dysregulation, involving writing, reading, or erasure, is linked to cancer development.
• Protein arginine methyltransferases (PRMTs) are identified as critical regulators of alternative splicing.

Purpose of the Study:

• To review the molecular mechanisms of PRMT-mediated alternative splicing regulation.
• To explore the link between aberrant PRMT-driven splicing and oncogenic processes.
• To discuss therapeutic strategies and challenges in targeting the PRMT-splicing axis in cancer.

Main Methods:

• Literature review of recent studies on PRMTs and alternative splicing.
• Analysis of molecular mechanisms linking PRMTs to splicing.
• Examination of oncogenic pathways affected by PRMT-driven splicing.
• Discussion of therapeutic implications and challenges.

Main Results:

• PRMTs play a crucial role in regulating alternative splicing.
• Aberrant splicing driven by PRMTs impacts tumor proliferation, apoptosis resistance, metastasis, and immune evasion.
• The PRMT-splicing axis represents a significant area for cancer research and therapeutic development.

Conclusions:

• PRMTs are central regulators of alternative splicing with profound implications in cancer.
• Targeting the PRMT-splicing axis offers potential therapeutic avenues for cancer treatment.
• Further research is needed to overcome challenges in developing effective PRMT-targeted therapies.